Table 3.
Placebo (N=122) | Rupatadine (N=119) | Desloratadine (N=118) | P-value (Chi-square test) | |
---|---|---|---|---|
Patients reported AEs (%) | 44 (36.1) | 47 (39.5) | 44 (37.3) | NS |
Drug-related AEs (%) | 12 (9.8) | 16 (13.4) | 19 (16.1) | NS |
Diarrhea | 0 (-) | 1 (0.8) | 3 (2.5) | NS |
Headache | 1 (0.8) | 2 (1.7) | 5 (4.2) | NS |
Somnolence | 0 (-) | 10 (8.4) | 7 (5.9) | NS |
Pharyngolaryngeal pain | 3 (2.5) | 0 (-) | 2 (1.7) | NS |
Withdrawals due to AEs | 0 | 0 | 0 | – |
Serious AEs | 1 | 0 | 0 | – |